BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Journal:
Nature Medicine
Published:
Affiliations:
23
Authors:
70
Institutions Authors Share
Cartesian Therapeutics, Inc., United States of America (USA)
28.000000
28.000000
28.000000
0.40
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
8.000000
0.11
University of California, San Francisco (UCSF), United States of America (USA)
5.500000
0.08
University of South Florida (USF), United States of America (USA)
4.000000
0.06
University Health Network (UHN), U of T, Canada
3.000000
0.04
University of California, Irvine (UCI), United States of America (USA)
2.000000
0.03
Neurology Associates PA, United States of America (USA)
2.000000
0.03
Neurology Center of Southern California, United States of America (USA)
2.000000
0.03
BioMap, China
2.000000
0.03
Istanbul University, Turkey
1.000000
0.01
Allegheny General Hospital (AGH), United States of America (USA)
1.000000
0.01
Augusta University, United States of America (USA)
1.000000
0.01
Center for Neurosciences, United States of America (USA)
1.000000
0.01
Dent Neurologic Institute, United States of America (USA)
1.000000
0.01
Houston Methodist Hospital, United States of America (USA)
1.000000
0.01
Tufts University, United States of America (USA)
1.000000
0.01
University of Alberta (U of A), Canada
1.000000
0.01
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.000000
0.01
University of Kansas Medical Center (KUMC), United States of America (USA)
1.000000
0.01
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.01
Vanderbilt University (VU), United States of America (USA)
1.000000
0.01
Virginia Commonwealth University (VCU), United States of America (USA)
1.000000
0.01
Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA)
0.500000
0.01